Mr. Damian Kettlewell reports

BLISSCO EARNS PRE-SALES LICENSE INSPECTION FROM HEALTH CANADA

Blissco Cannabis Corp. will complete a presales licence inspection from Health Canada in September, 2018. "Health Canada has completed their paper-based review of our application to amend our ACMPR licence to include the sale of dried cannabis, and we are excited to announce that our inspection will be completed in September," said Blissco chief executive officer Damian Kettlewell. "Our team is aligned and focused on successfully completing our multiday, presales inspection, and we are cautiously optimistic that we will earn our dried cannabis sales licence in November so that we can hit the ground running following legalization."

The Blissco team has been focused on scaling up its operations in preparation for commercialization by securing its oil production licence, developing an e-commerce strategy, building its network of partners and other high-impact initiatives.

"Dried cannabis products will represent Blissco's first chapter of commercialization; future products will be diversified but continue to be wellness focused. The large majority of our sales within a few years will be from cannabis oil tinctures, capsules, sublingual sprays, concentrates and edibles, with mixed ratios of CBD and THC," said Mr. Kettlewell.

About Blissco Cannabis Corp.

Blissco Cannabis is an ACMPR licensed producer and future distributor of ultrapremium cannabis. The company sits at the heart of an international ecosystem and is focused on the success of its domestic and global partnerships.

Blissco leverages the latest technology and is continuously developing its network of top-tier industry experts to drive the success of its brand and channels, moving premium Canadian cannabis to local and international markets.

Blissco is backed by an experienced team that is deeply in tune and integrated with industry partners and Blissco's future patients and customers.

We seek Safe Harbor.